Clinical Trial Update: A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early study investigating a novel inhaled melatonin formulation for adults with insomnia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Inhaled Melatonin (novel formulation) (melatonin)

Snippet

Sponsor: Woolcock Institute of Medical Research | Conditions: Insomnia | EARLY_Phase 1 | Status: RECRUITING